Study details
Enrolling now
Study to Evaluate Budesonide for Ulcerative Colitis in Children
Bausch Health Americas, Inc.
NCT IDNCT04314375ClinicalTrials.gov data as of Apr 2026
Phase
Phase 4
Target enrollment
70
Study length
about 3.8 years
Ages
5–17
Locations
4 sites in CA, IN, NC +1
About this study
Researchers are testing a treatment called budesonide, which is a type of medication, to see if it helps children with mild to moderate ulcerative colitis. The trial will last 1370 days and involve about 70 children who have active ulcerative colitis.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take High Dose Budesonide
- 2.Take Low Dose Budesonide
- 3.Take Placebo
PhasePhase 4
DrugLow Dose Budesonide
Routeoral
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low6%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ALIMENTARY TRACT AND METABOLISM
Drug routes
oral (Delayed Release Oral Capsule)
Body systems
Gastroenterology